Reneo Pharmaceuticals Financials

Reneo Pharmaceuticals Stock Summary

Reneo Pharmaceuticals competes with Prime Medicine,, Ginkgo Bioworks, Ocean Biomedical, Royalty Pharma, and Immix Biopharma. Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company was incorporated in 2014 and is headquartered in Irvine, California. Reneo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.

Reneo Pharmaceuticals Key Financial Ratios

Reneo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Reneo Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Reneo Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Reneo Pharmaceuticals competition to find correlations between indicators driving Reneo Pharmaceuticals's intrinsic value. More Info.Reneo Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Reneo Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Reneo Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Reneo Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Reneo Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Reneo Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Reneo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Reneo Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.